Shah Jaisim

Avg. Two Year Performance

(21%) Avg. Purchase Return
(10%) Compound
24% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(1%)(36%)(40%)83%(21%)
Purchase Success Rate1 of 32 of 31 of 32 of 31 of 3
Average Sale Return(3%)5%12%41%24%
Sale Success Rate2 of 64 of 65 of 66 of 64 of 6
Drugs » Biotechnology

SVP, Chief Business Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

See Remarks, Director:

Holdings: 203.22K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

SVP, Mktg & Bus. Affairs:

Holdings: 16.13K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Sr. VP - Business Development:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Financial Services » Diversified Investments

Director:

Holdings: 112.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--